laboratory equipment and services Environment and Pollution

Tumour Host Interactions Tender

🏛️ FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
📄 Tender ID: 499592603 📅 Published: 20 Jan 2024

📋 Tender Overview

Tumour-Host Interactions In Liver Cancer Of Childhood And Adults

Funded Under
Health
Total Cost
€ 10 396 703,00
Eu Contribution
€ 10 396 703,00
Coordinated By
Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I Sunyer
Spain

Objective

"Liver cancer is a major health problem with ~1 million cases diagnosed each year (~90,000 cases/year in Europe), and it is the 3rd cause of cancer-related mortality worldwide. Hepatocellular carcinoma (HCC) in adults, and hepatoblastoma (HB) in children are considered poorly understood cancers. HCC is a difficult-to-cure cancer (curation rate ~ 30%) with poor outcome (median survival < 2 years in advanced stages), due to limited understanding of at-risk populations, resistance to therapies and lack of precision oncology. In HB, outcomes are hampered in one fourth of cases due disease progression after surgical intervention and adjuvant chemotherapy.

THRIVE aims by to improve the outcome of both paediatric and adult liver cancer patients by understanding at-risk populations, tumour-host interactions, and by developing biomarkers for current therapies and novel, affordable treatments to overcome resistance. THRIVE brings together a strong, multidisciplinary team -13 partners, from 8 countries- with complementary expertise to leverage cutting-edge technologies (single-cell RNASeq, spatial transcriptomics, microbiota analysis, artificial intelligence, mouse models and patient-derived organoids) and sectors (i.e academia, SMEs, hospitals, patient associations) and 15 patient cohorts (~6,700 samples).

THRIVE expects to: 1) Define molecular features of cancer predisposition and at-risk populations for development of liver cancer. 2) Develop a complete human liver cancer blueprint of tumour, immune, stromal cells and intra-tumoral microbiomes. 3) Identify AI-based and molecular markers of response to treatments. 4) Implement a preclinical drug testing platform for discovery of affordable therapies with high social impact. 5) Maximize the impact in the European society by integrating SSH disciplines, delivering accessible and re-usable data and tools to support EU initiatives such as the UNCAN.eu platform, and by influencing policymakers and health professionals.

This action is part of the Cancer Mission cluster of projects on Understanding (tumour-host interactions)""."


🔍 Key Information

📄
Tender Reference No.
499592603
📅
Publication Date
20 Jan 2024
💰
Estimated Value
EUR 1039670300
🌐
Sector
laboratory equipment and services
📅
Deadline
30 Nov 2028
📝
Notice Type
Projects
📍
Location
Spain
📑
Contract Duration
4 Years 10 Months 10 Days

📁 Documents & Downloads

View All Documents →
# Document Name Type Action
2
T499592603.html
HTML

🏷️ CPV

No CPV found

Need help with this bid?

Our bid experts can help you find, evaluate & win more tenders.

🎧 Talk to Bid Expert
🕒 Submission deadline
746
days remaining · 30 Nov 2028
🔔 Set Alert

🧭 Quick Facts

Authority FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Country Spain
State / UT N/A
Tender Type Project Information
Currency EUR
Similar Tenders
Loading similar tenders…